CSPC Innovation Pharmaceutical (SHE:300765) recorded a net profit attributable to shareholders of 137 million yuan, dropping 48.3% from 264.9 million yuan a year earlier, according to a Saturday filing on the Shenzhen Stock Exchange.
Earnings per share fell 47.4% year on year to 0.10 yuan from 0.19 yuan.
The Chinese pharmaceutical company's revenue slipped 27.7% to 971.9 million yuan from 1.34 billion yuan in the preceding year, the disclosure said.
Price (RMB): ¥23.67, Change: ¥+0.19, Percent Change: +0.81%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments